
Biktarvy
Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.
Human immunodeficiency virus 1 (HIV-1) is a virus that weakens the immune system and can raise the risk of serious illness. Advanced HIV may lead to a group of serious illnesses once called AIDS.

Bictegravir, Emtricitabine, Tenofovir Alafenamide
50mg + 200mg + 25mg
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.

Tenofovir Disoproxil, Emtricitabine
300mg + 200mg
Tenofovir and emtricitabine tablets for HIV and pre-exposure prophylaxis. Combining two antivirals lowers the risk of resistance.

Emtricitabine, Tenofovir Disoproxil, Efavirenz
1.1gm
Efavirenz, emtricitabine and tenofovir tablets for HIV-1 infection. Combining three antiretrovirals lowers the chance of resistance.

Dolutegravir, Lamivudine, Tenofovir Disoproxil
50mg + 300mg + 300mg
Dolutegravir and lamivudine tablets for HIV-1 infection. It blocks two different steps in the HIV lifecycle.

Tenofovir Disoproxil, Efavirenz, Emtricitabine
300mg + 600mg + 200mg
Tenofovir disoproxil and efavirenz tablets for HIV-1. They combine two antiretrovirals to keep the virus in check.

400mg
Indinavir capsules for HIV-1 infection. It stops the virus from maturing into infectious particles.
The listed tablets and capsules include medicines containing Tenofovir Disoproxil and Emtricitabine. These are reverse transcriptase inhibitors; the catalogue also includes integrase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors. These medicine classes act at different stages of the HIV life cycle and relate to human immunodeficiency virus 1 (HIV-1) infection.